EQRx Debuts as Publicly Traded Company to Develop and Deliver Innovative Medicines at Radically Lower Prices Dec 17, 2021 12:45PM
EQRx to Accelerate Growth with $1.8 Billion Raise through Proposed Combination with CM Life Sciences III (CMLTU) Aug 6, 2021 07:14AM